Skip to Content

TE VA 7629 (Imatinib Mesylate 100 mg)

Pill with imprint TE VA 7629 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TE VA 7629

Imatinib mesylate 100 mg TE VA 7629

Imatinib Mesylate

Imprint
TE VA 7629
Strength
100 mg
Color
Brown
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7629
Inactive Ingredients
silicon dioxide, croscarmellose sodium, FD&C Yellow No. 6, hypromellose 2910 (6 mPa.s), ferric oxide yellow, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium stearyl fumarate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.